Pharmaceutical Management in Targeted Radioligand Therapy

Clinical trial NCT07389512 · RECRUITING

Trial details

NCT number: NCT07389512
Sponsor: Hospices Civils de Lyon
Status: RECRUITING
Study type: OBSERVATIONAL

Cancer Thyroid Cancer Metastatic Prostate Cancer Neuroendocrine Tumor Carcinoid

Start date: 2026-01-09
Primary completion: 2026-09-30
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.